Cambridge Epigenetix says raised $21 million, appoints Geoff Smith CEO
March 14, 2016Business Services, Sales and Marketing CEGX, CEO, Cambridge Epigenetix, fundraising, genome sequencing
Cambridge Epigenetix (CEGX) on Monday said it has raised about $21 million via Series B financing and named Geoff Smith …
Ariad names Manmeet Soni CFO
March 14, 2016Business Services, Sales and Marketing Ariad, CEO, appointment, boardroom, cfo
Ariad Pharmaceuticals Inc (Nasdaq: ARIA) named Manmeet Soni chief financial officer, effective March 21, 2016, succeeding Edward Fitzgerald. Mr Soni will …
Janssen’s Zytiga boosts survival in early-stage prostate cancer
March 14, 2016Research and Development, Sales and Marketing Janssen, Zytiga, abiraterone, prednisone, prostate cancer
Janssen has announced data from a post-hoc analysis of a Phase III trial showing that Zytiga plus prednisone boosted overall …
FDA approves Pfizer sNDA for Xalkori
March 14, 2016Research and Development, Sales and Marketing Cancer, EMA, NSCLC, Pfizer, Xalkori (crizotinib)
The US FDA has approved Pfizer’s supplemental new drug application (sNDA) for its kinase inhibitor Xalkori in treating patients with …
EMA starts review of Gilead Sciences’ Zydelig following safety concerns
March 14, 2016Research and Development, Sales and Marketing EMA, Gilead Sciences, blood cancer, clinical trials, zydelig
Regulators in Europe have initiated a safety review of Gilead Sciences’ (Nasdaq: GILD) blood cancer drug Zydelig (idelalisib) following reports …
GSK terminates Five Prime Therapeutics mesothelioma collaboration
March 14, 2016Research and Development, Sales and Marketing Five Prime Therapeutics, GSK, mesothelioma
GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …
Pfizer’s India unit stops production of cough drug, shares drop almost 8%
March 14, 2016Business Services, Sales and Marketing Bombay Stock Exchange, Corex, Pfizer Inc, Pfizer Ltd, Shares
Shares in the Indian arm of drug major Pfizer Inc (NYSE: PFE) dropped nearly 8% on the Bombay Stock Exchange …
MSF challenges Pfizer’s pneumonia vaccine patent in India
March 11, 2016Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine
The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
Spanish firm Grifols to spend a total of $360 million on four new plants
March 11, 2016Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production
Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey
March 11, 2016Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration
Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …
Novartis seeks expanded Arzerra use in US
March 11, 2016Research and Development Arzerra, CLL, FDA, Genmab, Novartis
Novartis has submitted a supplemental Biologics License Application (sBLA) to the US FDA for the use of Arzerra (ofatumumab) in …
Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal
March 11, 2016Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions
Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …
US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump
March 11, 2016Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA
Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
US Congress Committee pressures Valeant to produce drug pricing documents
March 11, 2016Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant
Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …
Teva funds research to protect fertility in women diagnosed with cancer
March 11, 2016Business Services, Research and Development Cancer, IVF Worldwide, Teva, fertility, radiotherapy
Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …
Alphabet’s life science unit makes device to aid gathering of health data for research
March 11, 2016Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences
Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …
Sanofi says its RA drug bested Humira in Phase III study
March 11, 2016Medical Communications, Research and Development Humira, Regeneron, Sanofi
Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …
Vericel stock nearly doubles as heart failure drug meets primary endpoint in mid-stage trial
March 11, 2016Medical Communications, Research and Development
Shares in US-based biotech firm Vericel nearly doubled on the Nasdaq on Thursday as the company reported its heart failure …
Novartis to unify Fougera’s US manufacturing plants
March 11, 2016Manufacturing and Production, Medical Communications Fougera, Novartis, Sandoz, manufacturing
Novartis is planning to unify the two manufacturing plants used by Sandoz unit Fougera Pharmaceuticals in the US, expanding and …
FDA grants approval for first generic version of Viagra
March 10, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra
The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
